FAIR VALUE MEASUREMENTS - SCHEDULE OF BUSINESS COMBINATION, CONTINGENT CONSIDERATION (Details) $ in Thousands |
9 Months Ended |
|---|---|
|
Sep. 27, 2026
USD ($)
| |
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |
| Changes in fair value | $ 43,797 |
| Payments | (19,087) |
| Contingent Consideration | |
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |
| Liability balance at December 31, 2025 | 77,820 |
| Liability balance at September 27, 2026 | $ 102,530 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|